New-onset diabetes after kidney transplantation: can the risk be modified by choosing immunosuppression regimen based on pretransplant viral serology?

Published: March 2nd, 2018

Category: published studies

T Cells

This study aimed to analyze adult kidney transplant recipients (KTRs) for the risk of new-onset diabetes after transplantation (NODAT) associated with viral serologies and immunosuppression regimens [tacrolimus (Tac) + mycophenolate (MPA), cyclosporine (CSA) + MPA, sirolimus (SRL) + MPA, SRL + CSA or SRL +Tac].

Read More: https://academic.oup.com/ndt/article/33/1/177/4554912

Santos AH JR, Chen C, Casey MJ, Womer, KL, Wen X. New-onset diabetes after kidney transplantation: can the risk be modified by choosing immunosuppression regimen based on pretransplant viral serology?. Nephrol Dial Transplant. 2018 Jan 1;33(1):177-184